4D Pharma Share Chat (DDDD)

Share Name	Share Symbol	Market	Type	Share ISIN	Share Description
4D Pharma	LSE:DDDD	London	Ordinary Share	GB00BJL5BR07	ORD 0.25P

	Price Change	% Change	Share Price	Bid Price	Offer Price	High Price	Low Price	Open Price	Shares Traded	Last Trade
	-6.50p	-2.57%	246.00p	237.00p	255.00p	264.75p	239.75p	264.75p	10,535	16:35:00

Industry Sector	Turnover (m)	Profit (m)	EPS - Basic	PE Ratio	Market Cap (m)
Pharmaceuticals & Biotechnology	0.0	-11.7	-15.2	-	158.34

4D Pharma Share Discussion Threads

Showing 76 to 94 of 100 messages

Chat Pages: 4 3 2 1

Date	Subject	Author	Discuss
04/7/2017 05:54	Valued at £147 million without a product??	hybrasil	Read Full Thread Reply
13/6/2017 23:54	Under Woodford's patient fund. But clearly a long way to go. Previous performance by competitors and a thorough analysis indicates 2021 or 2022 it is the right time/year to step in, maybe at a 25p bid price. At 260p today way too expensive! IMO	berkhath	Read Full Thread Reply
27/3/2017 15:59	Still feeling that opinion???	sandeep67	Read Full Thread Reply
28/9/2016 10:08	27/09/2016 UKREG Holding(s) in Company They way I read that is that Aviva Investors Global Services has lent out 830k shares worth £6mn whilst also reducing their position by 1.5mn shares to <3%	liquidkid	Read Full Thread Reply
26/9/2016 16:58	Ignore Liquid Underpants. He is a rancid little recluse who sits all day in the middle of a field digitally pleasuring himself. (He never manages the end bit, though, LOL LOL). He fancies himself as a bit of an investment guru and gives advice on all kinds of shares none of which he knows anything about. For instance he's been slagging off Woodford's Patient Capital Trust for aeons, quite impotently. Indeed in July he was shorting it, or so he claimed. He was trying to get other holders to do the same. So what happened? They shot up about 15%, that's all! He is also pretty thick about other financial matters. He says he avoids making a profit at all costs in case he has to pay Capital Gains Tax! Can you believe it? As if!!! He also excuses himself for always making losses by saying that they can be very useful to put against his tax liabilities. The dope hasn't twigged that you've got to make said gains before the losses can be used. He has also been making psychopathic fantasy posts pretending to smash those that disagree with him with a cricket bat about the head! Weird ain't a strong enough word.....	kpo115	Read Full Thread Reply
16/9/2016 16:09	Nice 10% rise today	ch1ck	Read Full Thread Reply
13/9/2016 08:43	I decided to buy back in to the stock today. Pharma stocks look like a solid play for the future and this looks to be an ideal takeover candidate or it will sell of some of its pipeline to a bug player who are actively looking for new products.	ch1ck	Read Full Thread Reply
17/8/2016 13:34	Hey, liquid kid, how's that short on WPCT that you were boasting about on July 4 getting on? I'll answer that: PATHETICALLY. What a Prat! What a totally failed investment guru! Mostly though, a complete loser.	kpo115	Read Full Thread Reply
17/8/2016 13:33	Hey, liquid kid, how's that short on WPCT that you were boasting about on July 4 getting on? I'll answer that: PATHETICALLY. What a Prat! What a totally failed investment guru! Mostly though, a complete loser.	kpo115	Read Full Thread Reply
04/8/2016 19:43	HTTP://www.cnbc.com/2016/07/29/gut-check-seres-therapeutics-shares-plunge-after-microbiome-drug-fails-in-trial.html	banshee	Read Full Thread Reply
04/8/2016 07:52	Woodford still keen on 4D's prospects... "Positive progress Since the period end, there has been some meaningfully positive and noteworthy news from several portfolio companies... 4D Pharma is at an earlier stage than Prothena but is establishing itself as a leading player in the emerging field of live biotherapeutics. It has announced very encouraging analysis on its phase I trial into a potential treatment for irritable bowel syndrome which will allow it to progress to the next stage of its clinical development." http://uk.advfn.com/stock-market/london/woodford-WPCT/share-news/Woodford-Patient-Capital-Trust-PLC-Half-year-Repor/72134460	someuwin	Read Full Thread Reply
15/6/2016 14:35	Wood haf expected the same drop as US peer Seres Therapeutics Inc (NASDAQ:MCRB) 30.51 -3.99 (-11.57%) Irish drugmaker Shire Plc said it would buy the rights to an experimental bowel drug from Pfizer Inc to bolster its pipeline of gastrointestinal treatments. The drug, is designed to treat moderate-to-severe inflammatory bowel disease, has successfully completed mid-stage studies. IBD includes ulcerative colitis (UC) and Crohn's disease (CD)	liquidkid	Read Full Thread Reply
31/3/2016 09:04	Results for the year ended 31 December 2015 "A fair value assessment of the acquired assets and liabilities (of Tucana) has not yet been completed at the date of this financial information and so a full disclosure of the valuation of the acquired assets and liabilities has not been made." How can 4D Justify value of this investment? Well, it doesn't have to until next year end! Not that there were any assets anyway. Tucana Health Limited was set up on Wednesday the 6th of January 2016. to investigate microbiome signatures. 4D Pharma acquired Tucana on 10 Feb 16.	liquidkid	Read Full Thread Reply
30/3/2016 16:04	Recovering well. getting close to previous highs.	someuwin	Read Full Thread Reply
24/2/2016 09:47	4D are creating live biotherapeutic (microbiome) treatments for major diseases... Clinical trials underway for IBS. Trials about to start for Crohn's Disease Identified an orally administered candidates that had shown efficacy in pre-clinical models of: Asthma, Allergic asthma, Rheumatoid arthritis, Multiple sclerosis, Breast cancer, Lung Cancer. ...More to come. Plus multi-million pound collaboration on microbiome treatment for Autism Plus Acquired start-up microbiome diagnostics company Tucana Health. i.e massive potential here. Microbiome modification is at the heart of revolutionary health science. 4D and OPTI are right at the heart of it.	someuwin	Read Full Thread Reply
23/2/2016 16:11	Looks as though there is an offensive on at the moment hyping up this company. HTTP://labiotech.eu/europes-richest-microbiome-biotech-acquires-irish-start-up-to-accelerate/ 'Tucana’s R&D is closely related to two of the company’s products: Blautix, a therapy for Irritable Bowel Syndrome (IBS) currently in Phase I clinical trials that seems to be having promising results, and MicroRx, a proprietary library of gut microbiota.' HTTP://apc.ucc.ie/spin-out-company-tucana-health-ltd-creates-jobs-in-cork/ '4D pharma’s investment will be used to build further research capability in Tucana Health, and to hire key research staff.' - This was a paid in shares acquisition. No cash 'Longer term the company will focus on building a diagnostic platform across multiple disease areas mirroring the programmes developed by MicroRx' - So they are going to do the same thing in the hope of getting a different answer?	liquidkid	Read Full Thread Reply
23/2/2016 14:24	Creeping up again.	someuwin	Read Full Thread Reply
22/2/2016 15:22	Must be more trial results coming soon.	someuwin	Read Full Thread Reply
20/1/2016 11:38	The trial on the 'healthy individuals' well it, Didn't kill them. Didn't make them stronger either. In the Companys cunning simple plan One of the four D's is; Develop: Development is a significant expense so only do proof of concept milestone. So are they going to stop scratching around the IBS here and ask for more money? I'm all for enhancing 'good' bacteria but the company really looks like the pond scum of an investment. The most advanced product within the programme, ThetanixTM, comprises a naturally occurring bacteria found in the gut of healthy individuals. And WTF does 'brain-gut-microbiota axis' even mean? "Without the micro-biota, life could not exist, and we would have no knowledge of the Force. They continually speak to us, telling us the will of the Force. When you learn to quiet your mind, you'll hear them speaking to you." Qui-Gon Jinn, to Anakin SkyWoodford	liquidkid	Read Full Thread Reply

Chat Pages: 4 3 2 1

Your Recent History

LSE

GKP

Gulf Keyst..

LSE

QPP

Quindell

FTSE

UKX

FTSE 100

LSE

IOF

Iofina

FX

GBPUSD

UK Sterlin..

Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil

ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico

ADVFN France ADVFN US Finance Manila

P:41 V: D:20170728 19:05:46